5 Best Diabetes Stocks To Buy Now

Page 5 of 5

1. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 88

Big pharma Johnson & Johnson (NYSE:JNJ) tops the list of 10 best diabetes stocks to buy now. The New Jersey-based healthcare firm markets Invokana, an FDA-approved type 2 diabetic medication that decreases blood sugar in adults while also lowering the risk of stroke and heart attack. 

Johnson & Johnson (NYSE:JNJ) also manufactures consumer health products, medical devices, and other prescription medications to treat cancer, hypertension, psoriasis, and chronic brain disorders such as schizophrenia. Johnson & Johnson (NYSE:JNJ) is also one of the biggest vaccine makers in the world. On October 20, the FDA approved the drugmaker’s single booster shot for people aged 18 and up.

The drug manufacturer saw a 10.7% year-over-year total sales growth to $23.3 billion in the third quarter of 2021. Shares of Johnson & Johnson (NYSE:JNJ) climbed 13% in the past twelve months.

Jayson Bedford of Raymond James maintained an Outperform rating on Johnson & Johnson (NYSE:JNJ) and set a price target of $178 per share. 

You can also take a peek at the 10 High-Yield Dividend Stocks to Buy According to Ken Fisher and Nancy Pelosi Stock Portfolio: 10 Stocks To Consider.

Page 5 of 5